HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,373,065 | +5.2% | 26,491 | 0.0% | 0.05% | +13.6% |
| Q2 2023 | $2,255,445 | +9.4% | 26,491 | +6.3% | 0.04% | +10.0% |
| Q1 2023 | $2,062,214 | +9.2% | 24,921 | +3.8% | 0.04% | +8.1% |
| Q4 2022 | $1,888,702 | +623.6% | 24,014 | +581.6% | 0.04% | +640.0% |
| Q3 2022 | $261,000 | -54.9% | 3,523 | -32.3% | 0.01% | -28.6% |
| Q1 2021 | $579,000 | -13.1% | 5,205 | -7.1% | 0.01% | -12.5% |
| Q4 2020 | $666,000 | -67.7% | 5,605 | -76.3% | 0.01% | -68.0% |
| Q3 2020 | $2,061,000 | -73.9% | 23,608 | -73.2% | 0.02% | -73.1% |
| Q2 2020 | $7,884,000 | -10.1% | 88,017 | -0.0% | 0.09% | -19.8% |
| Q1 2020 | $8,773,000 | -9.7% | 88,020 | +4.1% | 0.12% | +17.2% |
| Q4 2019 | $9,713,000 | -8.6% | 84,520 | +0.4% | 0.10% | -8.3% |
| Q3 2019 | $10,624,000 | +1.0% | 84,220 | -3.7% | 0.11% | -1.8% |
| Q2 2019 | $10,521,000 | +46.4% | 87,423 | +6.4% | 0.11% | +41.0% |
| Q1 2019 | $7,186,000 | -11.6% | 82,128 | +1.1% | 0.08% | -27.1% |
| Q4 2018 | $8,129,000 | -9.2% | 81,231 | +4.0% | 0.11% | +1.9% |
| Q3 2018 | $8,953,000 | +5.1% | 78,137 | -17.7% | 0.10% | 0.0% |
| Q2 2018 | $8,516,000 | +2.6% | 94,949 | -16.3% | 0.10% | -1.9% |
| Q1 2018 | $8,301,000 | -0.8% | 113,457 | -21.2% | 0.11% | -3.6% |
| Q4 2017 | $8,368,000 | +3.2% | 144,066 | -20.3% | 0.11% | +1.8% |
| Q3 2017 | $8,107,000 | +10.8% | 180,660 | -2.5% | 0.11% | +5.8% |
| Q2 2017 | $7,320,000 | -2.5% | 185,348 | +0.2% | 0.10% | -4.6% |
| Q1 2017 | $7,508,000 | +2.2% | 185,049 | +1.3% | 0.11% | +3.8% |
| Q4 2016 | $7,347,000 | +25.8% | 182,746 | +13.3% | 0.10% | +19.5% |
| Q3 2016 | $5,839,000 | +221.0% | 161,239 | +157.0% | 0.09% | +190.0% |
| Q2 2016 | $1,819,000 | -12.6% | 62,737 | +5.5% | 0.03% | -26.8% |
| Q1 2016 | $2,081,000 | +155.3% | 59,486 | +135.3% | 0.04% | +127.8% |
| Q4 2015 | $815,000 | -0.5% | 25,278 | -0.2% | 0.02% | -10.0% |
| Q3 2015 | $819,000 | +68.5% | 25,338 | +116.1% | 0.02% | +81.8% |
| Q2 2015 | $486,000 | -46.0% | 11,727 | -41.4% | 0.01% | -50.0% |
| Q1 2015 | $900,000 | -24.5% | 20,023 | -37.1% | 0.02% | -33.3% |
| Q4 2014 | $1,192,000 | +34.4% | 31,830 | +17.0% | 0.03% | +10.0% |
| Q1 2014 | $887,000 | -22.7% | 27,210 | 0.0% | 0.03% | -25.0% |
| Q4 2013 | $1,147,000 | +28.3% | 27,210 | +21.4% | 0.04% | +25.0% |
| Q3 2013 | $894,000 | -3.6% | 22,410 | 0.0% | 0.03% | -5.9% |
| Q2 2013 | $927,000 | – | 22,410 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |